Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Front Immunol. 2022 Jun 29;13:900254. doi: 10.3389/fimmu.2022.900254. eCollection 2022.
Atherosclerosis is one of the main complications of diabetes mellitus, involving a variety of pathogenic factors. Endothelial dysfunction, inflammation, and oxidative stress are hallmarks of diabetes mellitus and atherosclerosis. Although the ability of diabetes to promote atherosclerosis has been demonstrated, a deeper understanding of the underlying biological mechanisms is critical to identifying new targets. NLRP3 plays an important role in both diabetes and atherosclerosis. While the diversity of its activation modes is one of the underlying causes of complex effects in the progression of diabetes and atherosclerosis, it also provides many new insights for targeted interventions in metabolic diseases.
动脉粥样硬化是糖尿病的主要并发症之一,涉及多种致病因素。内皮功能障碍、炎症和氧化应激是糖尿病和动脉粥样硬化的标志。尽管糖尿病促进动脉粥样硬化的能力已得到证实,但深入了解潜在的生物学机制对于确定新的靶点至关重要。NLRP3 在糖尿病和动脉粥样硬化中都发挥着重要作用。虽然其激活模式的多样性是导致糖尿病和动脉粥样硬化进展中复杂效应的原因之一,但它也为代谢性疾病的靶向干预提供了许多新的见解。